Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 23.30B | 23.65B | 23.97B | 24.34B | 26.27B | 31.10B |
Gross Profit | 12.67B | 13.70B | 13.49B | 14.35B | 15.50B | 18.94B |
EBITDA | 2.54B | 4.74B | 2.43B | 5.85B | 7.71B | 11.41B |
Net Income | 1.35B | 1.65B | 1.29B | 1.34B | 5.19B | 6.34B |
Balance Sheet | ||||||
Total Assets | 52.10B | 54.63B | 52.04B | 53.16B | 46.08B | 46.05B |
Cash, Cash Equivalents and Short-Term Investments | 34.33B | 28.38B | 30.96B | 34.07B | 25.72B | 30.99B |
Total Debt | 7.10B | 6.10B | 7.10B | 10.20B | 4.21B | 5.31B |
Total Liabilities | 12.08B | 13.18B | 11.83B | 14.41B | 7.84B | 10.28B |
Stockholders Equity | 40.00B | 41.44B | 40.19B | 38.73B | 38.23B | 35.77B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.80B | -325.00M | 4.63B | 3.90B | 9.93B |
Operating Cash Flow | 0.00 | 3.87B | -84.00M | 5.05B | 4.79B | 10.01B |
Investing Cash Flow | 0.00 | -1.47B | -77.00M | 1.19B | -3.01B | -4.77B |
Financing Cash Flow | 0.00 | -2.14B | -3.23B | 4.94B | -4.19B | -3.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥50.39B | 57.64 | ― | -13.60% | 5.59% | ||
68 Neutral | ¥12.32B | 18.70 | 1.67% | 1.15% | -8.55% | ||
64 Neutral | ¥41.46B | 55.28 | 3.30% | -10.86% | -64.25% | ||
64 Neutral | ¥12.80B | 9.00 | ― | 4.13% | ― | ||
60 Neutral | $44.16B | 2.09 | -11.99% | 4.01% | 2.29% | -39.41% | |
50 Neutral | ¥31.23B | 15.38 | ― | -25.89% | ― |